Biovail
Biovail
Biovail (/baɪoʊveɪl/) is a term often used in the field of pharmaceutical industry and biotechnology. It refers to a former Canadian company that was one of the country's largest publicly traded pharmaceutical companies. Biovail was involved in the research, development, production, and marketing of pharmaceutical products.
Etymology
The term "Biovail" is a portmanteau of the words "bio", derived from the Greek word "bios" meaning life, and "avail", an English word meaning to be of use or advantage. The name reflects the company's mission to make biological solutions available for improving human health.
History
Biovail Corporation was founded in 1989 by Eugene Melnyk. The company specialized in the development and commercialization of advanced drug delivery technologies and formulations. In 2010, Biovail merged with Valeant Pharmaceuticals, another Canadian pharmaceutical company, and the combined entity continued under the Valeant name.
Related Terms
- Pharmaceutical Industry: The branch of the chemical industry that discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications.
- Biotechnology: A technology based on biology, especially when used in agriculture, food science, and medicine.
- Valeant Pharmaceuticals: A multinational specialty pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products.
External links
- Medical encyclopedia article on Biovail
- Wikipedia's article - Biovail
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski